{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 11,
        "end": 15
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 55,
        "end": 59
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 134,
        "end": 140
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 190,
        "end": 194
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 190,
        "end": 209
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 85,
        "end": 95
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22179112_4",
  "text": "Moreover , Rhes ( - / - ) mice showed reduced striatal mTOR signaling and diminished dyskinesia , but maintained motor improvement on L-DOPA treatment , suggesting a therapeutic benefit for Rhes -binding drugs ."
}
